Document is current
Any future updates will be listed below
-
Authors
Mendiratta, Mohini
Mendiratta, Meenakshi
Ganguly, Shuvadeep
Rai, Sandeep
Gupta, Ritu
Kumar, Lalit
Bakhshi, Sameer
Dadhwal, Vatsla
Pushpam, Deepam
Malik, Prabhat Singh
Pramanik, Raja
Aggarwal, Mukul
Gupta, Aditya Kumar
Dhawan, Rishi
Seth, Tulika
Mahapatra, Manoranjan
Nayak, Baibaswata
Singh, Thoudam Debraj
Kumar, Sachin
Mir, Riyaz Ahmed
Kaur, Gurvinder
GuruRao, Hariprasad
Singh, Mayank
Prasad, Chandra Prakash
Prakash, Hridayesh
Mohanty, Sujata
Sahoo, Ranjit Kumar
-
Funding
Funding for this research was provided by:
Indian Council of Medical Research (2021/14763)
- License Information
-
More Information
Article History
Received: 29 April 2024
Accepted: 18 September 2024
First Online: 29 October 2024
Declarations
:
: The study involved the use of human subjects only and was approved by the Institute Ethics Committee for Post Graduate Research, All India Institute of Medical Sciences, New Delhi, India (Title: Immunomodulatory properties of Mesenchymal Stem Cells in Graft-versus-host-disease; Ref. No.: IECPG-542/23.09.2020; 24.09.2020). The study involved the use of human mesenchymal stem cells and was approved by the Institutional Committee for Stem Cell Research, All India Institute of Medical Sciences, New Delhi, India (Title: Immunomodulatory properties of Mesenchymal Stem Cells in Graft-versus-host-disease; Ref. No.: IC-SCR/110/20(R); 31.12.2020). Informed written consents were obtained from all participating subjects and all procedures were performed as per the guidelines and regulations approved by the ethics committee
: Not applicable.
: The authors declare that they have no competing interests.
